Compositions comprising HIV protease inhibitor and cytochrome P450 enzyme activity inhibitor

Details for Australian Patent Application No. 2005216712 (hide)

Owner Pfizer Inc.

Inventors Smith, Evan Burr; Tran, Jonathan Quoc

Agent Shelston IP

Pub. Number AU-A-2005216712

PCT Pub. Number WO2005/082364

Priority 60/614,997 01.10.04 US; 60/540,746 30.01.04 US

Filing date 17 January 2005

Wipo publication date 9 September 2005

International Classifications

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/00 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/082364 Priority application(s): WO2005/082364

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216720-Novel process for treating foods under alternating atmospheres

2005216710-Therapeutic combinations